DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC

M. Saksoe, K. Jensen, M. Andersen, J.G. Eriksen, J. Overgaard

Research output: Contribution to journalConference abstract in journalResearchpeer-review

3 Downloads (Pure)
Original languageEnglish
Article numberOC-041
JournalRadiotherapy and Oncology
Volume132
Issue numberSuppl. 1
Pages (from-to)21-22
Number of pages2
ISSN0167-8140
DOIs
Publication statusPublished - Mar 2019
Event7th ICHNO: International Conference on Innovative Approaches in Head & Neck Oncology - Barcelona, Spain
Duration: 14 Mar 201916 Mar 2019
Conference number: 7
https://www.esmo.org/Conferences/Past-Conferences/ICHNO-2019-Head-Neck-Cancer

Conference

Conference7th ICHNO: International Conference on Innovative Approaches in Head & Neck Oncology
Number7
CountrySpain
CityBarcelona
Period14/03/201916/03/2019
Internet address

Cite this

Saksoe, M. ; Jensen, K. ; Andersen, M. ; Eriksen, J.G. ; Overgaard, J. / DAHANCA 28a : Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC. In: Radiotherapy and Oncology. 2019 ; Vol. 132, No. Suppl. 1. pp. 21-22.
@article{03faa9700b884e158dd86316e19960b8,
title = "DAHANCA 28a: Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC",
author = "M. Saksoe and K. Jensen and M. Andersen and J.G. Eriksen and J. Overgaard",
year = "2019",
month = "3",
doi = "10.1016/S0167-8140(19)30207-5",
language = "English",
volume = "132",
pages = "21--22",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier",
number = "Suppl. 1",

}

DAHANCA 28a : Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC. / Saksoe, M.; Jensen, K.; Andersen, M.; Eriksen, J.G.; Overgaard, J.

In: Radiotherapy and Oncology, Vol. 132, No. Suppl. 1, OC-041, 03.2019, p. 21-22.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

TY - ABST

T1 - DAHANCA 28a

T2 - Phase I/II study of acc. hyperfractionated RT, cisplatin and nimorazole in P16-LAHNSCC

AU - Saksoe, M.

AU - Jensen, K.

AU - Andersen, M.

AU - Eriksen, J.G.

AU - Overgaard, J.

PY - 2019/3

Y1 - 2019/3

U2 - 10.1016/S0167-8140(19)30207-5

DO - 10.1016/S0167-8140(19)30207-5

M3 - Conference abstract in journal

VL - 132

SP - 21

EP - 22

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

IS - Suppl. 1

M1 - OC-041

ER -